Anti-IL-1 beta antibody [EPR23851-127] (Ab254360)
IL1F2, IL1B, Interleukin-1 beta, IL-1 beta, Catabolin
用户验证的应用
推荐稀释比例
- WB1/1000
- ICC/IF1/50
- Flow Cyt (Intra)1/2500
详细信息
背景信息
Anti-IL-1 beta antibody [EPR23851-127] (ab254360) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF and WB. Anti-IL-1 beta antibody [EPR23851-127] (ab254360) was first used in a scientific publication in 2021 and has been cited over 96 times in peer reviewed journals. It's performance in Western blot in human, mouse and rat samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-IL-1 beta antibody [EPR23851-127] (ab254360) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-IL-1 beta antibody [EPR23851-127] (ab254360) has been confirmed by ICC/IF testing in IL-1 beta knockout THP-1 cells ( ab273762 ). Anti-IL-1 beta antibody [EPR23851-127] (ab254360) specifically detects IL-1 beta (UniProt ID: P10749; Molecular weight: 18kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPR23851-127 - ab282021. Antibody clone EPR23851-127 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 647 ( ab317662, ab319085 ). Interleukin-1 beta (IL-1β) is a key biomarker in inflammatory bowel disease (IBD). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (271)
Immune-activating PTL/nanowire composite coating on Ti surface enables macrophage-driven bacterial clearance and osseointegration.
在钛表面涂覆免疫激活PTL/纳米线复合涂层，可实现巨噬细胞驱动的细菌清除和骨整合。
Piezo1-Targeted Magnetoacoustic Nanobubbles Rescue Alzheimer's Pathology by Electromechanical Neuromodulation and Amyloid-β Clearance.
靶向压电1的磁声纳米气泡通过电机械神经调节和淀粉样蛋白β清除来挽救阿尔茨海默病病理。
NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development.
黑素细胞中 NLRP3 自噬降解紊乱是导致白癜风发生的原因之一。
Flipping the Switch: MeCP2-Mediated Lactylation Rewires Microglial Metabolism and Inflammation via the HK2/mTOR Axis in Poststroke Neuroinflammation.
扭转乾坤：MeCP2 介导的乳酸化通过 HK2/mTOR 轴重塑中风后神经炎症中的小胶质细胞代谢和炎症。
Mesenchymal Stem Cell-Derived Apoptotic Micro-Vesicles Repaired Sciatic Nerve Defect by Regulating Early Inflammatory Microenvironment and Promoting Angiogenesis.
间充质干细胞衍生的凋亡微囊泡通过调节早期炎症微环境和促进血管生成修复坐骨神经缺陷。
An autonomous siRNA delivery system targeting NLRP3: implications in Parkinson's disease.
靶向 NLRP3 的自主 siRNA 递送系统：对帕金森病的影响。
Aging-Associated Nox4-Mediated Mitochondrial Reactive Oxygen Species and DNA Damage Promote Vascular Cell Reprogramming and Aortic Remodeling in Abdominal Aneurysms.
衰老相关的 Nox4 介导的线粒体活性氧和 DNA 损伤促进腹主动脉瘤血管细胞重编程和主动脉重塑。
Revealing FPR1 as a potential pathogenic biomarker for aortic dissection based on Mendelian randomization, single-cell transcriptome and clinical data analysis.
基于孟德尔随机化、单细胞转录组和临床数据分析，揭示 FPR1 是主动脉夹层的潜在致病生物标志物。
NRG1 Suppresses NLRP3 Inflammasome Activation and Endothelial-Mesenchymal Transition in Cerebral Ischemia-Reperfusion Injury: Association with the AKT/NF-κB Pathway.
NRG1抑制脑缺血再灌注损伤中的NLRP3炎症小体激活和内皮-间质转化：与AKT/NF-κB通路相关。
Preservation of circulatory death donor Rat hearts using hemoglobin-based oxygen carriers for normothermic machine perfusion: enhancing viability and functionality.
利用基于血红蛋白的氧载体进行常温机器灌注，保存循环死亡供体大鼠心脏：提高活力和功能。
- 1
- 2
- 3
- 4
- 5
- 6
- 28